Vertex Pharmaceuticals Inc. Q3 Profit Increases, Beats Estimates

(RTTNews) - Vertex Pharmaceuticals Inc. (VRTX) announced a profit for its third quarter that Increased from the same period last year and beat the Street estimates.

The company's bottom line totaled $1.082 billion, or $4.20 per share. This compares with $1.045 billion, or $4.01 per share, last year.

Excluding items, Vertex Pharmaceuticals Inc. reported adjusted earnings of $1.236 billion or $4.80 per share for the period.

Analysts on average had expected the company to earn $4.58 per share. Analysts' estimates typically exclude special items.

The company's revenue for the period rose 11.0% to $3.076 billion from $2.771 billion last year.

Vertex Pharmaceuticals Inc. earnings at a glance (GAAP) :

-Earnings: $1.082 Bln. vs. $1.045 Bln. last year. -EPS: $4.20 vs. $4.01 last year. -Revenue: $3.076 Bln vs. $2.771 Bln last year.

-Guidance: Full year revenue guidance: $11.9 - $12.0 Bln